NCT01044745 2023-09-06Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerUniversity of NebraskaPhase 2 Terminated20 enrolled 8 charts
NCT00118352 2017-05-30Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed12 enrolled 10 charts
NCT00416624 2017-02-10Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyMayo ClinicPhase 2 Completed239 enrolled 23 charts